Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 9,480 shares at $20.12 ($191K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($191k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.12 | 4,207 | $85K | 44.4% |
| 2 | $20.12 | 4,207 | $85K | 44.4% |
| 3 | $20.11 | 1,066 | $21K | 11.2% |
| Total | $20.12 avg | 9,480 | $191K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |